Nuveen Asset Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $925K | Hold |
103,517
| – | – | ﹤0.01% | 2744 |
|
|
2024
Q3 | $1.14M | Sell |
103,517
-194,520
| -65% | -$2.14M | ﹤0.01% | 2698 |
|
|
2024
Q2 | $2.71M | Buy |
298,037
+90,840
| +44% | +$827K | ﹤0.01% | 2232 |
|
|
2024
Q1 | $2.92M | Buy |
207,197
+105,031
| +103% | +$1.48M | ﹤0.01% | 2223 |
|
|
2023
Q4 | $785K | Buy |
102,166
+2,290
| +2% | +$17.6K | ﹤0.01% | 2835 |
|
|
2023
Q3 | $745K | Buy |
99,876
+8,485
| +9% | +$63.3K | ﹤0.01% | 2694 |
|
|
2023
Q2 | $761K | Buy |
+91,391
| New | +$761K | ﹤0.01% | 2766 |
|
|
2021
Q2 | – | Sell |
-13,933
| Closed | -$241K | – | 3299 |
|
|
2021
Q1 | $241K | Buy |
13,933
+920
| +7% | +$15.9K | ﹤0.01% | 3204 |
|
|
2020
Q4 | $167K | Buy |
13,013
+1,022
| +9% | +$13.1K | ﹤0.01% | 3215 |
|
|
2020
Q3 | $445K | Sell |
11,991
-6,070
| -34% | -$225K | ﹤0.01% | 2985 |
|
|
2020
Q2 | $697K | Buy |
+18,061
| New | +$697K | ﹤0.01% | 2779 |
|